GL1X · GenesisL1 explorer

MolNFT v1 · #124180 · protein

Design and optimization of biaryl ether aryl sulfonamides as selective inhibitors of NAV1.7: discovery of clinical candidate pf-05089771

5K7K: “Design and optimization of biaryl ether aryl sulfonamides as selective inhibitors of NAV1.7: discovery of…”. X-ray diffraction, 2 ligands (HEM, 6RJ). MolNFT v1 #124180 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5K7K
Type
protein
Length
455 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P11712
Ligands
HEM, 6RJ

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein455—P11712

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • 6RJ · 4-[4-chloranyl-2-(1~{H}-pyrazol-4-yl)phenoxy]-3-cyano-~{N}-(1,3-thiazol-2-yl)benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5K7K · Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P11712 · AlphaFold monomer V2.0 prediction for cytochrome P450 2C9 (P11712) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.